These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 6228478)

  • 1. Effect of genetic background on the therapeutic effects of dehydroepiandrosterone (DHEA) in diabetes-obesity mutants and in aged normal mice.
    Coleman DL; Schwizer RW; Leiter EH
    Diabetes; 1984 Jan; 33(1):26-32. PubMed ID: 6228478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic effects of dehydroepiandrosterone (DHEA) and its metabolites in obese-hyperglycemic mutant mice.
    Coleman DL
    Prog Clin Biol Res; 1988; 265():161-75. PubMed ID: 2970093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic effects of dehydroepiandrosterone metabolites in diabetes mutant mice (C57BL/KsJ-db/db).
    Coleman DL; Leiter EH; Applezweig N
    Endocrinology; 1984 Jul; 115(1):239-43. PubMed ID: 6234160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic effects of dehydroepiandrosterone (DHEA) in diabetic mice.
    Coleman DL; Leiter EH; Schwizer RW
    Diabetes; 1982 Sep; 31(9):830-3. PubMed ID: 6219024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dehydroepiandrosterone decreases elevated hepatic glucose production in C57BL/KsJ-db/db mice.
    Aoki K; Taniguchi H; Ito Y; Satoh S; Nakamura S; Muramatsu K; Yamashita R; Ito S; Mori Y; Sekihara H
    Life Sci; 2004 May; 74(25):3075-84. PubMed ID: 15081573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytochemical analysis of pancreatic islet hypercytolipidemia following diabetes (db/db) and obese (ob/ob) mutation expression: influence of genomic background.
    Garris DR; Garris BL
    Pathobiology; 2004; 71(5):231-40. PubMed ID: 15459481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic analysis of obesity-induced diabetes associated with a limited capacity to synthesize insulin in C57BL/KS mice: evidence for polygenic control.
    Kaku K; Province M; Permutt MA
    Diabetologia; 1989 Sep; 32(9):636-43. PubMed ID: 2676665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dehydroepiandrosterone suppresses elevated hepatic glucose-6-phosphatase mRNA level in C57BL/KsJ-db/db mice: comparison with troglitazone.
    Aoki K; Kikuchi T; Mukasa K; Ito S; Nakajima A; Satoh S; Okamura A; Sekihara H
    Endocr J; 2000 Dec; 47(6):799-804. PubMed ID: 11228057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgenic and estrogenic metabolites in serum of mice fed dehydroepiandrosterone: relationship to antihyperglycemic effects.
    Leiter EH; Beamer WG; Coleman DL; Longcope C
    Metabolism; 1987 Sep; 36(9):863-9. PubMed ID: 2957567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of plasma lipids in genetically obese mice: the mutants obese, diabetes, fat, tubby, and lethal yellow.
    Nishina PM; Lowe S; Wang J; Paigen B
    Metabolism; 1994 May; 43(5):549-53. PubMed ID: 8177042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ciglitazone, a new hypoglycemic agent. I. Studies in ob/ob and db/db mice, diabetic Chinese hamsters, and normal and streptozotocin-diabetic rats.
    Chang AY; Wyse BM; Gilchrist BJ; Peterson T; Diani AR
    Diabetes; 1983 Sep; 32(9):830-8. PubMed ID: 6354790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dehydroepiandrosterone suppresses the elevated hepatic glucose-6-phosphatase and fructose-1,6-bisphosphatase activities in C57BL/Ksj-db/db mice: comparison with troglitazone.
    Aoki K; Saito T; Satoh S; Mukasa K; Kaneshiro M; Kawasaki S; Okamura A; Sekihara H
    Diabetes; 1999 Aug; 48(8):1579-85. PubMed ID: 10426376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of diabetes, hepatic injury, and colon cancer with dehydroepiandrosterone.
    Aoki K; Nakajima A; Mukasa K; Osawa E; Mori Y; Sekihara H
    J Steroid Biochem Mol Biol; 2003 Jun; 85(2-5):469-72. PubMed ID: 12943737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DHEA-PC slows the progression of type 2 diabetes (non-insulin-dependent diabetes mellitus) in the ZDF/Gmi-fa/fa rat.
    Byrne JJ; Bradlow HL
    Diabetes Technol Ther; 2001; 3(2):211-9. PubMed ID: 11478327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphometric analysis of obesity (ob/ob)- and diabetes (db/db)-associated hypothalamic neuronal degeneration in C57BL/KsJ mice.
    Garris DR
    Brain Res; 1989 Oct; 501(1):162-70. PubMed ID: 2804691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiobesity effects of etiocholanolones in diabetes (db), viable yellow (Avy), and normal mice.
    Coleman DL
    Endocrinology; 1985 Dec; 117(6):2279-83. PubMed ID: 2933245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal relationship of tissue somatostatin-like immunoreactivity to metabolic changes in genetically obese and diabetic mice.
    Berelowitz M; Coleman DL; Frohman LA
    Diabetes; 1980 Sep; 29(9):717-23. PubMed ID: 6108273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogenic restoration of functional pancreatic islet cytoarchitecture in diabetes (db/db) mutant C57BL/KsJ mice: relationship to estradiol localization, systemic glycemia, and persistent hyperinsulinemia.
    Garris DR; Garris BL
    Cell Tissue Res; 2005 Feb; 319(2):231-42. PubMed ID: 15654653
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential beta cell responses to hyperglycaemia and insulin resistance in two novel congenic strains of diabetes (FVB- Lepr (db)) and obese (DBA- Lep (ob)) mice.
    Chua S; Liu SM; Li Q; Yang L; Thassanapaff VT; Fisher P
    Diabetologia; 2002 Jul; 45(7):976-90. PubMed ID: 12136396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced cardiac efficiency and altered substrate metabolism precedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity.
    Buchanan J; Mazumder PK; Hu P; Chakrabarti G; Roberts MW; Yun UJ; Cooksey RC; Litwin SE; Abel ED
    Endocrinology; 2005 Dec; 146(12):5341-9. PubMed ID: 16141388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.